;PMID: 3424709 ;source_file_1886.mrg ;Release 0.9 of PennBioIE ;Funded by NSF ITR EIA-0205448 ;0)section:[e:0..30] = [t:0..30] ;1)sentence:[e:36..113] = [t:36..113] ;2)section:[e:117..137] = [t:117..137] ;3)section:[e:141..175] = [t:141..175] ;4)sentence:[e:179..519] = [t:179..519] ;5)section:[e:523..567] = [t:523..567] ;section 0 Span:0..30 ;Vopr Onkol. 1987;33(12):67-71. (SEC (FRAG (NNP:[0..4] Vopr) (NNP:[5..10] Onkol) (.:[10..11] .) (CD:[12..16] 1987) (CD:[16..19] ;33) (-LRB-:[19..20] -LRB-) (CD:[20..22] 12) (-RRB-:[22..23] -RRB-) (::[23..24] :) (CD:[24..26] 67) (::[26..27] -) (CD:[27..29] 71) (.:[29..30] .))) ;sentence 1 Span:36..113 ;[Metabolic characteristics of xenobiotics in the liver of tumor-bearing ;rats] ;[66..77]:substance:"xenobiotics" (SENT (NP-HLN (-LRB-:[36..37] -LSB-) (NP (JJ:[37..46] Metabolic) (NNS:[47..62] characteristics)) (PP (IN:[63..65] of) (NP (NNS:[66..77] xenobiotics))) (PP (IN:[78..80] in) (NP (NP (DT:[81..84] the) (NN:[85..90] liver)) (PP (IN:[91..93] of) (NP (ADJP (NN:[94..99] tumor) (HYPH:[99..100] -) (VBG:[100..107] bearing)) (NNS:[108..112] rats))))) (-RRB-:[112..113] -RSB-))) ;section 2 Span:117..137 ;[Article in Russian] (SEC (FRAG (-LRB-:[117..118] -LSB-) (NN:[118..125] Article) (IN:[126..128] in) (NNP:[129..136] Russian) (-RRB-:[136..137] -RSB-))) ;section 3 Span:141..175 ;Komov VP, Firsova VI, Vennikas OR. (SEC (FRAG (NNP:[141..146] Komov) (NN:[147..149] VP) (,:[149..150] ,) (NNP:[151..158] Firsova) (NNP:[159..161] VI) (,:[161..162] ,) (NNP:[163..171] Vennikas) (NNP:[172..175] OR.))) ;sentence 4 Span:179..519 ;A study of the condition and function of a multienzymatic monoxygenase system ;in liver microsomes of rats bearing experimental Pliss' lymphosarcoma and ;Zajdela's ascites hepatoma showed synthesis and function of the key enzymes ;of the hydroxylating microsomes of the liver being inhibited and, ;consequently, drug metabolism slowed down. ;[237..249]:substance:"monoxygenase" ;[401..408]:substance:"enzymes" ;[490..494]:substance:"drug" (SENT (S (NP-SBJ (NP (DT:[179..180] A) (NN:[181..186] study)) (PP (IN:[187..189] of) (NP (NP (DT:[190..193] the) (NN:[194..203] condition) (CC:[204..207] and) (NN:[208..216] function)) (PP (IN:[217..219] of) (NP (NP (DT:[220..221] a) (JJ:[222..236] multienzymatic) (NN:[237..249] monoxygenase) (NN:[250..256] system)) (PP (IN:[257..259] in) (NP (NP (NN:[261..266] liver) (NNS:[267..277] microsomes)) (PP (IN:[278..280] of) (NP (NP (NNS:[281..285] rats)) (VP (VBG:[286..293] bearing) (NP (NP (JJ:[294..306] experimental) (NP (NNP:[307..312] Pliss) (POS:[312..313] ')) (NN:[314..327] lymphosarcoma)) (CC:[328..331] and) (NP (NP (NNP:[332..339] Zajdela) (POS:[339..341] 's)) (NNS:[343..350] ascites) (NN:[351..359] hepatoma))))))))))))) (VP (VBD:[360..366] showed) (S (S (NP-SBJ (NP (NN:[367..376] synthesis) (CC:[377..380] and) (NN:[381..389] function)) (PP (IN:[390..392] of) (NP (NP (DT:[393..396] the) (JJ:[397..400] key) (NNS:[401..408] enzymes)) (PP (IN:[409..411] of) (NP (NP (DT:[412..415] the) (VBG:[417..430] hydroxylating) (NNS:[431..441] microsomes)) (PP (IN:[442..444] of) (NP (DT:[445..448] the) (NN:[449..454] liver)))))))) (VP (VBG:[455..460] being) (VP (VBN:[461..470] inhibited)))) (CC:[471..474] and) (,:[474..475] ,) (S (ADVP (RB:[476..488] consequently)) (,:[488..489] ,) (NP-SBJ (NN:[490..494] drug) (NN:[496..506] metabolism)) (VP (VBD:[507..513] slowed) (PRT (RB:[514..518] down)))))) (.:[518..519] .))) ;section 5 Span:523..567 ;PMID: 3424709 [PubMed - indexed for MEDLINE] (SEC (FRAG (NNP:[523..527] PMID) (::[527..528] :) (CD:[529..536] 3424709) (NN:[537..538] -LSB-) (NNP:[538..544] PubMed) (::[545..546] -) (NN:[547..554] indexed) (IN:[555..558] for) (NNP:[559..567] MEDLINE-RSB-)))